Home›Companies›Biotech & Pharma›Barricade Therapeutics

Barricade Therapeutics Corp

Develops an experimental oral treatment for people with colorectal cancer.

Updated Nov 10, 2026·Latest SEC filing Jun 10, 2026·Suggest an edit

About Barricade Therapeutics

Barricade Therapeutics is a private company based in Fort Worth, Texas. It has reported $100,000 raised in one offering on Form D since June 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 27, 2026Jun 10, 2026$100,000target not set1$100KSAFERule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Barricade Therapeutics's Form D filed Jun 10, 2026.

Neil Thapar
Neil Thapar
Executive officer

Sources

  1. SECBarricade Therapeutics Corp filing history
  2. CompanyBarricade Therapeutics team